Metabolic Disorders


Investigational Treatment Shows Potential to Supress Memory Loss

September 15, 2020

Aaron Burstein, PharmD, shares details from a scientific presentation at the Alzheimer's Association International Conference.

Family History of Diabetes: Is There an Association With Nonaffective Psychosis?

January 31, 2020

New insights on the association between family history of type 2 diabetes and comorbid diabetes in patients with schizophrenia and other nonaffective psychoses.

Mini Quiz: Diabetes Distress and Anxiety

July 24, 2019

What do we know about psychiatric symptoms that may present in patients who also have diabetes? Take the quiz and learn more.

Silver Linings After Abuse and Neglect

July 04, 2018

The neuroprotective role of resilience in patients with schizophrenia who experienced early childhood trauma is evaluated in this brief update.

Is There a Relationship Between Mood and Diet?

March 08, 2018

Are we happier when we don’t eat sugar or gluten and should we all be gluten-free?

IBS and the Developing Microbiome

March 02, 2018

In this exclusive interview, Psyched! podcast hosts continue the conversation with a leading researcher on mind-gut connections.

The Mind-Gut Connection: What Is It and How Did It Evolve?

February 21, 2018

An expert talks about his interest in the mind’s relationship to the GI tract, some basics of what bacterial gut/brain communication is, and the evolutionary biology theories behind it.

Lifestyle, Personality, and Metabolic Changes in the Elderly

February 12, 2018

Three new studies on genetic risk factors and lifestyle; the transition from cognitive health to Alzheimer disease; and metabolic syndrome in depressed older adults.

Expert Q&A: Schizophrenia and Weight Gain

September 14, 2017

Schizophrenia and T2 DM risk; short-term weight gain with specific antipsychotics; interventions to reduce weight and/or metabolic abnormalities. . .answers here.

Metabolic Monitoring of Antipsychotic Medications: What Psychiatrists Need to Know

May 29, 2017

Because patients who have psychiatric illnesses typically receive less frequent medical care, psychiatrists must aim to ensure appropriate monitoring of metabolic parameters when antipsychotic medications are used.